The Biden administration recently warned that Medicare could spend $3.5 billion on a new category of Alzheimer's drugs in 2025 alone – a figure vastly higher than what experts in the field predict – leading many to question the math.
Marvell Adams Jr.
Advertisement
Articles by Marvell Adams Jr.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Medical Economics
1
How physicians are really using AI in 2025
2
The new era of physician independence
3
Denied claims and AI, with Clarissa Riggins of Experian Health
4
Hubly Surgical gains FDA Clearance for expanded use of auto-stop drill in spinal procedures
5
